Acromegaly NZ

Support & education for those with acromegaly & their families

Category: For our Acromegaly NZ Members

  • Pharmac to Fund Lanreotide from March 2025

    PHARMAC will publicly fund lanreotide (Mytolac) in New Zealand starting 1 March 2025 for acromegaly, improving treatment access and allowing easier transitions from octreotide.

  • Communicating Life with Acromegaly

    Acromegaly affects both individuals and their loved ones, causing communication barriers, emotional struggles, and physical discomfort. Open communication, education, and patience are essential for maintaining supportive relationships and intimacy.

  • Living Well with Acromegaly

    Managing acromegaly involves building a partnership with healthcare providers, embracing a healthy lifestyle, tackling symptoms directly, and seeking specialised care when needed for personalised support.

  • Triumph Over Adversity

    Frances, despite health challenges, excelled at the recent Harbour Crossing event in Auckland. Her inspiring journey encourages strength, unity, and perseverance. Read her story in The Valley Profile.